246
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study

, , , , &
Pages 1859-1868 | Published online: 31 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Norio Sugawara, Norio Yasui-Furukori, Toshinaga Tsuji, Shinji Hayashi, Yoshikazu Ajisawa, Toshimitsu Ochiai, Hideyuki Imagawa & Kazutaka Shimoda. (2020) The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms. Neuropsychiatric Disease and Treatment 16, pages 3063-3070.
Read now

Articles from other publishers (17)

Jingyi Wang, Sue Paul, Renee Noel Arbet & Alex C. Lin. (2022) Application of Pharmacogenomics Testing in a Community-based Facility. Hospital Pharmacy 58:1, pages 98-105.
Crossref
Ketema Zerihun Asefa, Tadele Degefa Bedada, Jaleta Abdisa Fufa, Firomsa Shewa Gari, Gurmessa Nugussu Gelcho & Geremew Muleta Akessa. (2023) Predictors of time to first symptomatic recovery of major depressive disordered patients: a case study at Jimma University Medical Center. BMC Psychiatry 23:1.
Crossref
E. Papalexi, A. Galanopoulos, D. Roukas, I. Argyropoulos, I. Michopoulos, A. Douzenis, I. Gkolia, P. Fotiadis, D. Kontis & I.M. Zervas. (2022) Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD). Journal of Affective Disorders 314, pages 185-192.
Crossref
Jennifer Wild, Aimee McKinnon, Abbie Wilkins & Haddi Browne. (2021) Post‐traumatic stress disorder and major depression among frontline healthcare staff working during the COVID‐19 pandemic. British Journal of Clinical Psychology 61:3, pages 859-866.
Crossref
Shinichi Noto, Mayumi Wake, Izumi Mishiro, Lene Hammer-Helmich, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 30, pages 127-133.
Crossref
Vanessa M. Oddo, Lauren Welke, Andrew McLeod, Lacey Pezley, Yinglin Xia, Pauline Maki, Mary Dawn Koenig, Michelle A. Kominiarek, Scott Langenecker & Lisa Tussing-Humphreys. (2022) Adherence to a Mediterranean Diet Is Associated with Lower Depressive Symptoms among U.S. Adults. Nutrients 14:2, pages 278.
Crossref
Adele M. Hayes, Carly Yasinski & Elizabeth Alpert. 2022. Clinical Guide to Exposure Therapy. Clinical Guide to Exposure Therapy 317 345 .
Mario Luciano, Claudia Carmassi & Umberto Albert. 2022. Recovery and Major Mental Disorders. Recovery and Major Mental Disorders 225 244 .
Sigal Zilcha-Mano, Xuemei Wang, Dalia B. Wajsbrot, Matthieu Boucher, Stuart A. Fine & Bret R. Rutherford. (2021) Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials. Journal of Clinical Psychopharmacology 41:5, pages 579-584.
Crossref
Quan Gao & Hye Eun Lee. (2021) How Framed Messages Influence Depression Assessment Intentions: Interactivity of Social Media as a Moderator. International Journal of Environmental Research and Public Health 18:4, pages 1787.
Crossref
Candace Jones & Charles B. Nemeroff. 2021. Major Depressive Disorder. Major Depressive Disorder 535 563 .
D. Kontis, D. Roukas, P. Panagiotidis, E. Kalogera, C. Anagnostara, E. Karavelas, E. Papalexi & A. Galanopoulos. (2020) P.330 Functioning and functional recovery in outpatients with major depressive disorder in Greece treated with vortioxetine. European Neuropsychopharmacology 40, pages S192-S193.
Crossref
Constança Carvalho, Filipa Peste, Tiago A. Marques, Andrew Knight & Luís M. Vicente. (2020) The Contribution of Rat Studies to Current Knowledge of Major Depressive Disorder: Results From Citation Analysis. Frontiers in Psychology 11.
Crossref
Jennifer SevereJohn F. GredenPriyanka Reddy. (2020) Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?. FOCUS 18:2, pages 120-128.
Crossref
Kristin Heuschkel & Kim P.C. Kuypers. (2020) Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review. Frontiers in Psychiatry 11.
Crossref
JAVIER BARTOLOMEI, RACHEL BAERISWYL-COTTIN, DAVID FRAMORANDO, ADRIANO ZANELLO, JEAN-PIERRE BACCHETTA, FRANÇOIS HERRMANN & OTHMAN SENTISSI. (2020) Personality Factors and Attachment Styles as Predictors of the Therapeutic Efficacy of a Short-Term Ambulatory Intervention for Depression. Journal of Psychiatric Practice 26:1, pages 3-16.
Crossref
Kourosh Amini, Dougie Marks, Mohammad Ali Cheraghi, Mehrdad Eftekhar & Reza Negarandeh. (2018) Attempting to Restore Integrity of the Self: A Grounded Theory Study of Recovery From Major Depressive Disorder. Journal of the American Psychiatric Nurses Association 25:5, pages 385-395.
Crossref